CBD Oil for Depression in New Zealand: 2026 Clinical Evidence and Access

Frequently Asked Questions

Does medicinal cannabis work for depression? In 2026, the answer depends on whether you are looking for a standalone psychiatric treatment or a tool to support mood while managing chronic health conditions. Two significant pieces of recent research point in different directions and understanding both is essential before considering this pathway.³

Quick summary: A major Lancet Psychiatry review in 2026 found no evidence from randomised control studies for treating primary depression with cannabinoids alone. However, in University of Otago research from the same year, New Zealanders managing persistent pain reported meaningful improvements in mood and quality of life while using CBD oil prescribed for chronic pain and endometriosis.⁴

Medically Reviewed by: Dr William Parkyn, Medical Director

Is CBD legal in New Zealand?

Yes. Medicinal cannabis is a prescription only medicine in New Zealand and is regulated under the Medicinal Cannabis Scheme, which has been in place since 2020.⁵

You cannot legally buy CBD oil over the counter or have it shipped from overseas. The only legal route is through a consultation with a registered medical practitioner, such as a GP or specialist clinician.

What does the 2026 research say about CBD oil and depression?

The conversation around medicinal cannabis for depression often pulls in two different types of research. Large scale reviews look at randomised control studies for primary psychiatric conditions. Real world observational studies look at how patients actually feel when managing chronic illness.

The Lancet Psychiatry published a large review in March 2026.³ It looked at 54 randomised controlled trials spanning 45 years and concluded that there is no clear evidence medicinal cannabis effectively treats primary depression or anxiety as a standalone psychiatric treatment. It notes that there is a lack of evidence in this area and so it should be noted that lack of evidence is not the same as evidence of no benefit.

A different study from the University of Otago, published in January 2026, told a different story for a specific patient group.⁴ It followed New Zealanders using medicinal cannabis for endometriosis and chronic pelvic pain. Patients reported meaningful improvements in their quality of life, including better sleep and reduced anxiety. Some described being able to return to work or to activities they had previously had to give up.⁴

 

Feature	Lancet Psychiatry review (2026)	University of Otago study (2026)
Study type	Meta analysis of 54 trials	Prospective observational cohort
Primary focus	Primary psychiatric disorders	Chronic pain and quality of life
Key finding	No evidence for primary depression	Significant improvement in mood
Patient group	Broad psychiatric samples	NZ patients with chronic pelvic pain
Implication	Needs more targeted RCTs	Useful for secondary mood symptoms

 

The honest read of these two studies: CBD oil is not a first line treatment for clinical depression on its own, but some patients managing persistent physical pain or chronic illness report that it helps them carry the emotional load that comes with it. Whether that could apply to your situation is a conversation to have with a doctor.

Curious whether your situation might suit this pathway? Take the private Quiz.

How does CBD oil affect mood?

Every person has an endocannabinoid system (ECS), a network of receptors and natural chemicals that helps regulate mood, sleep, and pain. Unlike THC, which is the component in cannabis that produces a high, CBD is non intoxicating and works differently.⁸

Research suggests CBD interacts with some of the brain’s serotonin receptors. Serotonin is the chemical messenger most often linked with mood stability and a sense of wellbeing.⁹ By supporting how these receptors respond, CBD may help maintain a more stable baseline mood. This is a developing area of research, not a settled clinical promise.

There is also early evidence that CBD may support neurogenesis, which is simply the brain’s way of creating new cells. Long term stress and depression are known to slow this process. Researchers are exploring whether CBD plays a helpful role here, but this is early stage science, not something proven in patients yet.⁹

How do you get CBD oil prescribed in New Zealand?

A clinical consultation is designed to be supportive and transparent. It begins with a doctor reviewing your medical history and existing medications to make sure medicinal cannabis is a safe option for you. This matters particularly if you take antidepressant or anti-anxiety medication, because CBD can interact with some of these. The clinician reviews this to check that medicinal cannabis would be safe alongside your current treatment.

The pathway typically looks like this:

• Initial review. A registered NZ doctor examines your health records and symptoms.
• Suitability assessment. The clinician decides whether medicinal cannabis is appropriate based on current NZ guidelines.
• Personalised plan. If eligible, you receive a tailored plan that usually starts with a low dose and is adjusted based on your response.
• Ongoing support. Most clinics offer access to a nursing team for questions about dosing or how you are feeling.

It is important to flag that higher THC is not automatically better for mood. Where a clinician does consider medicinal cannabis as part of a wider picture, CBD dominant or low THC formulations are more typical than high THC products.

CBD oil side effects and driving in NZ

Pure CBD products do not typically impair your ability to drive. Many medicinal cannabis prescriptions, however, involve a balance of CBD and small amounts of THC. If your treatment includes THC, your clinician will advise a stand down period before driving based on your prescription. Never drive while impaired.²

CBD is generally well tolerated, but some people experience mild side effects, most often dry mouth, mild drowsiness, fatigue, or a change in appetite. Most of these settle as your body adjusts.

Key takeaways

• CBD oil is legal in NZ when prescribed by a registered doctor and is regulated under the Medicinal Cannabis Scheme.
• The 1 February 2026 rule change allows prescriptions of up to 12 months for stable conditions.
• The 2026 Lancet Psychiatry review found no clear evidence for cannabinoids as a standalone treatment for primary depression.
• In the 2026 University of Otago study, NZ patients managing chronic pelvic pain and endometriosis reported meaningful improvements in mood and quality of life.
• Higher THC is not automatically better. CBD dominant formulations are typical for mood related use.
• Medicinal cannabis is most appropriate when conventional treatments have not provided enough relief.

Where to start

If conventional treatment has not given you the relief you need, exploring whether you qualify for a regulated medical pathway is a reasonable next step. You can begin with the Eligibility Quiz, or book a consultation if you would prefer to ask questions first. For more information on the legal status and quality of products in New Zealand, the Ministry of Health page is a useful resource: https://www.health.govt.nz/regulation-legislation/medicinal-cannabis/information-for-consumers

Depression can be heavy to carry. If you are finding things hard right now, talk to your GP, or free call or text 1737 at any time to speak with a trained counsellor.

References

1. Ministry of Health NZ. Information for consumers about medicinal cannabis. https://www.health.govt.nz/regulation-legislation/medicinal-cannabis/information-for-consumers
2. New Zealand Police. Updates to drug driving legislation. https://www.police.govt.nz/advice-services/drugs-and-alcohol/updates-drug-driving-legislation
3. Wilson, J., et al. (2026). The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis. The Lancet Psychiatry, 13(4).
4. Henry, C., et al. (2026). Perceived impact of medicinal cannabis on pelvic pain and endometriosis-related symptoms in Aotearoa New Zealand: an observational cohort study. BMC Complementary Medicine and Therapies, 26(1).
5. Medsafe NZ. Medicinal Cannabis Scheme now operational. https://www.medsafe.govt.nz/profs/PUArticles/June2020/Medicinal-Cannabis-Scheme-now-operational.html
6. Ministry of Health NZ. Medicinal cannabis Minimum Quality Standard. https://www.health.govt.nz/regulation-legislation/medicinal-cannabis/information-for-health-professionals/minimum-quality-standard-medicinal-cannabis-products
7. Beehive.govt.nz. Easier and cheaper prescriptions for Kiwis. https://www.beehive.govt.nz/release/easier-and-cheaper-prescriptions-kiwis
8. Hill, M. N., Campolongo, P., Yehuda, R., & Patel, S. (2017). Integrating endocannabinoid signaling and cannabinoids into the biology and treatment of posttraumatic stress disorder. Neuropsychopharmacology, 43(1), 80-102. https://doi.org/10.1038/npp.2017.162
9. Campos, A. C., Fogaca, M. V., Sonego, A. B., & Guimaraes, F. S. (2016). Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacological Research, 112, 119-127. https://doi.org/10.1016/j.phrs.2016.01.033
10. Gulbransen, G., Xu, W., & Arroll, B. (2020). Cannabidiol prescription in clinical practice: an audit of 400 patients in New Zealand. BJGP Open, 4(1). https://doi.org/10.3399/bjgpopen20X101010